Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

Relationship of neurotransmitters to the symptoms of major depressive disorder.

Nutt DJ.

J Clin Psychiatry. 2008;69 Suppl E1:4-7. Review.

2.

The other face of depression, reduced positive affect: the role of catecholamines in causation and cure.

Nutt D, Demyttenaere K, Janka Z, Aarre T, Bourin M, Canonico PL, Carrasco JL, Stahl S.

J Psychopharmacol. 2007 Jul;21(5):461-71. Epub 2006 Oct 18. Review.

PMID:
17050654
3.

[A new concept of antidepressant drugs action: clinical and preclinical data].

Płaźnik A, Kostowski W.

Psychiatr Pol. 1994 Jan-Feb;28(1):39-50. Review. Polish.

PMID:
7910691
4.

Emerging drugs for major depressive disorder.

Kennedy SH, Rizvi SJ.

Expert Opin Emerg Drugs. 2009 Sep;14(3):439-53. doi: 10.1517/14728210903107751. Review.

PMID:
19637989
5.

Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression.

Trivedi MH, Hollander E, Nutt D, Blier P.

J Clin Psychiatry. 2008 Feb;69(2):246-58. Review.

PMID:
18363453
6.
7.

Biological basis of depression and therapeutic relevance.

Richelson E.

J Clin Psychiatry. 1991 Jun;52 Suppl:4-10. Review. Erratum in: J Clin Psychiatry 1991 Aug;52(8):353.

PMID:
1646793
8.

A clinical perspective on the role of neurotransmitters in mental disorders.

Brown RP, Mann JJ.

Hosp Community Psychiatry. 1985 Feb;36(2):141-50. Review.

PMID:
2579012
9.

Models of antidepressant action.

Berman RM, Charney DS.

J Clin Psychiatry. 1999;60 Suppl 14:16-20; discussion 31-5. Review.

10.

Major depressive disorder: remission of associated symptoms.

Trivedi MH.

J Clin Psychiatry. 2006;67 Suppl 6:27-32. Review.

12.

Clinical strategies for evaluating ECT mechanisms--pharmacological, biochemical and psychophysiological approaches.

Lerer B, Sitaram N.

Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(2-3):309-33.

PMID:
6137030
13.

Physiological effects of electroconvulsive therapy and transcranial magnetic stimulation in major depression.

Szuba MP, O'Reardon JP, Evans DL.

Depress Anxiety. 2000;12(3):170-7. Review.

PMID:
11126192
14.

Postmortem neurochemical studies in depression.

Ferrier IN, McKeith IG, Cross AJ, Perry EK, Candy JM, Perry RH.

Ann N Y Acad Sci. 1986;487:128-42. No abstract available.

PMID:
2436529
15.

Catecholaminergic strategies for the treatment of major depression.

Tremblay P, Blier P.

Curr Drug Targets. 2006 Feb;7(2):149-58. Review.

PMID:
16475956
16.
17.

Depression: the case for a monoamine deficiency.

Delgado PL.

J Clin Psychiatry. 2000;61 Suppl 6:7-11. Review.

18.

Brain noradrenaline and the mechanisms of action of antidepressant drugs.

Svensson TH.

Acta Psychiatr Scand Suppl. 2000;402:18-27. Review.

PMID:
10901155
19.

Current investigational drugs for major depression.

Kulkarni SK, Dhir A.

Expert Opin Investig Drugs. 2009 Jun;18(6):767-88. doi: 10.1517/13543780902880850 . Review.

PMID:
19426122
20.

Neurochemical aspects of depression: the past and the future?

Jesberger JA, Richardson JS.

Int J Neurosci. 1985 Jul;27(1-2):19-47. Review.

PMID:
2991156

Supplemental Content

Support Center